Nitrile gloves have become extremely difficult to find – and expensive – thanks to Covid-19. Amid accusations of profiteering, everyone from Malaysian rubber magnates to Polish upstarts are cashing in.
Category: /worlds-billionaires
This College Professor Became An Overnight Billionaire Fighting Covid
Carl Hansen’s Abcellera Biologics scored big helping Eli Lilly develop antibodies to treat symptoms of Covid-19.
Jeff Bezos Once Again The World’s Richest Person After Rollercoaster Week
The Amazon founder ended the week on top of the world, but he wasn’t one of the 10 biggest gainers of the past 7 days.
Billionaire Mark Cuban Wants To Lower Drug Prices With Generics Startup
The Dallas, Texas-based company aims to introduce transparency into the supply chain and sell 100 different generic drugs by the end of year.
Inside The Two Biotech Companies Working Together On A Covid-19 Vaccine For Cats
The shot could be effective for dogs, minks and zoo animals, too.
Meet The 50 Doctors, Scientists And Healthcare Entrepreneurs Who Became Pandemic Billionaires In 2020
A surge in healthcare stocks has minted more than four dozen new billionaires from just that sector this year, driven largely by the impact of the Covid-19 pandemic.
Bill Gates Has Big, Scientific Hopes For 2021. Here’s Why.
In a new blog post, the billionaire and philanthropist explains why he thinks next year will be better than 2020.
The Feds’ Risky Billion Dollar Bet On Moderna Pays Off As FDA Authorizes Its Covid-19 Vaccine
In early 2020, the federal government took a gamble on a plucky startup that had never had an approved medication could produce a Covid-19 vaccine. On Friday, it got paid off as Moderna’s vaccine got a regulatory signoff and will start being distribute…
Khosla-Backed Health AI Startup Raises $27.5 Million To Supercharge Primary Care
With his San Francisco-based startup Curai, Neal Khosla, son of billionaire investor Vinod Khosla, wants to dramatically reduce healthcare costs.
Why A Tech Billionaire’s $50 Million Bet On A Covid Testing Firm Is Still Waiting For FDA Approval
Diagnostic firm Fluxergy’s pivot to Covid-testing was supposed to give it a huge boost – but even with backing from Kingston Technology’s John Tu, it’s stuck in limbo.
